Ian Stuart Young

Ian Stuart Young

Auto-generated profile, based on publicly available information

Ian Stuart Young

Centre for Public Health Queen's University Belfast Belfast UK

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2001 in Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
IYI S Young
I S Young
JWJayne Woodside
Jayne Woodside
Free radical production occurs continuously in all cells as part of normal cellular function. However, excess free radical production originating from endogenous or exogenous sources might play a role in many diseases. Antioxidants prevent free radical induced tissue damage by preventing the formation of radicals, scavenging them, or by promoting their decomposition. This article reviews the basic chemistry of free radical formation in the body, the consequences of free radical induced tissue damage, and the function of antioxidant defence systems, with particular reference to the development of atherosclerosis.

1 April 2006 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
CACristina A Augood
Cristina A Augood
JVJohannes R Vingerling
Johannes R Vingerling
PJPaulus T V M De Jong
Paulus T V M De Jong
UCUsha Chakravarthy
Usha Chakravarthy
JSJohan Seland
Johan Seland
AFAstrid E Fletcher
Astrid E Fletcher
To estimate the prevalence of age-related maculopathy in an older population from 7 European countries. Randomly sampled people 65 years and older were invited to an eye examination in centers across 7 European countries (Norway, Estonia, United Kingdom, France, Italy, Greece, and Spain). Fundus images of each eye were graded at a single reading center. Prevalence rates were calculated for stage of age-related maculopathy with 95% confidence intervals (CIs) estimated for clustered data. Of 5040 participants (45% response rate), 4753 (2128 men and 2625 women) had gradable fundus images. The prevalences were grade 0, 47.59% (95% CI, 43.53%-51.65%); grade 1, 36.48% (95% CI, 32.66%-40.30%); grade 2, 10.14% (95% CI, 8.92% to 11.37%); grade 3, 2.46% (95% CI, 1.79%-3.13%); and grade 4 (age-related macular degeneration [AMD]), 3.32% (95% CI, 2.52%-4.13%) and large drusen only (> or = 125 microm), 15.41% (95% CI, 13.61%-17.21%). The prevalence of geographic atrophic AMD was 1.2% (95% CI, 0.8%-1.7%) and of neovascular AMD, 2.3% (95% CI, 1.7%-2.9%). The prevalence of bilateral AMD was 1.4% (95% CI, 1.0%-1.8%). Age-specific prevalences of age-related maculopathy in the European Eye Study (EUREYE) are similar to other population-based studies in Western populations.

1 October 1995 in Fertility and Sterility
Verified
Journal Article
Closed access
SLSheena E.M. Lewis
Sheena E.M. Lewis
PBPaul M. Boyle
Paul M. Boyle
KMKaren A. McKinney
Karen A. McKinney
IYIan S. Young
Ian S. Young
WTWilliam Thompson
William Thompson

19 February 2013 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
ISINMA-Valencia Cohort Study
INMA-Valencia Cohort Study
Jesus VioqueJesus Vioque
Jesus Vioque
Eva Maria Navarrete-MuñozEva Maria Navarrete-Muñoz
Eva Maria Navarrete-Muñoz
Daniel Gimenez-MonzoDaniel Gimenez-Monzo
Daniel Gimenez-Monzo
MHManuela Garcia-de-la Hera
Manuela Garcia-de-la Hera
CICarmen Iñiguez
Carmen Iñiguez
Studies exploring the role of diet during pregnancy are still scarce, in part due to the complexity of measuring diet and to the lack of valid instruments. The aim of this study was to examine the reproducibility and validity (against biochemical biomarkers) of a semi-quantitative food frequency questionnaire (FFQ) in pregnant women.

1 January 1997 in Fertility and Sterility
Verified
Journal Article
Closed access
SLSheena E.M. Lewis
Sheena E.M. Lewis
ESE. Samantha L. Sterling
E. Samantha L. Sterling
IYIan S. Young
Ian S. Young
WTWilliam Thompson
William Thompson

1 August 1996 in QJM: An International Journal of Medicine
Verified
Journal Article
Open access
PDF file
DHD.L. Harmon
D.L. Harmon
JWJayne Woodside
Jayne Woodside
JYJ.W.G. Yarnell
J.W.G. Yarnell
DMD. McMaster
D. McMaster
IYI.S. Young
I.S. Young
AEA.E. Evans
A.E. Evans
Mild hyperhomocysteinaemia is a major risk factor for vascular disease and neural tube defects (NTDs), conferring an approximately three-fold relative risk for each condition. It has several possible causes: heterozygosity for rare loss of function mutations in the genes for 5,10-methylene tetrahydrofolate reductase (MTHFR) or cystathionine-β-synthase (CBS); dietary insufficiency of vitamin co-factors B6, B12 or folates; or homozygosity for a common ‘thermolabile’ mutation in the MTHFR gene which has also been associated with vascular disease and NTDs. We quantified the contribution of the thermolabile mutation to the hyperhomocysteinaemic phenotype in a working male population (625 individuals). Serum folate and vitamin B12 concentrations were also measured and their relationship with homocysteine status and MTHFR genotype assessed. The homozygous thermolabile genotype occurred in 48.4, 35.5, and 23.4% of the top 5,10, and 20% of individuals (respectively) ranked by plasma homocysteine levels, compared with a frequency of 11.5% in the study population as a whole, establishing that the mutation is a major determinant of homocysteine levels at the upper end of the range. Serum folate concentrations also varied with genotype, being lowest in thermolabile homozygotes. The MTHFR thermolabile genotype should be considered when population studies are designed to determine the effective homocysteine-lowering dose of dietary folate supplements, and when prophylactic doses of folate are recommended for individuals.